Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease

Por P.L. Meroni, F. Allegri, L. Andreoli, S. Piantoni, A. Tincani
Publicado em 2012-12-01

Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience

Por R. Cattaneo, M. Ferrari, S. Archetti, L. Andreoli, M. Taraborelli, A. Tincani
Publicado em 2011-06-01

Study of a Low-Cost Piezoelectric Sensor for Three Phase Induction Motor Load Estimation

Por Guilherme B. Lucas, Bruno A. de Castro, Marco A. Rocha, Andre L. Andreoli
Publicado em 2019-02-01

Typing TREX1 gene in patients with systemic lupus erythematosus

Por M. Fredi, M. Bianchi, L. Andreoli, G. Greco, I. Olivieri, S. Orcesi, E. Fazzi, C. Cereda, A. Tincani
Publicado em 2015-06-01

Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center

Por F. Dall'Ara, I. Cavazzana, M. Frassi, M. Taraborelli, M. Fredi, F. Franceschini, L. Andreoli, M. Rossi, C. Cattaneo, A. Tincani, P. Airò
Publicado em 2018-07-01

Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive?

Por R.A. Sinico, C. Corace, A. Radice, F. Allegri, V. Fanelli, R.W. Burlingame, F. Pregnolato, L. Andreoli, A. Tinconi, P.L. Meroni
Publicado em 2011-09-01

Subpopulations of anti-β2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β2glycoprotein I

Por P.L. Meroni, T. Avcin, A. Lojacono, M. Frassi, M. Nuzzo, W.L. Binder, G.L. Norman, M. Motta, C. Nalli, L. Andreoli, A. Tincani
Publicado em 2011-06-01

P6.18 CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS; ARE THERE ANY DIFFERENCES?

Por A. Paini*, L. Andreoli, M. Salvetti, F. Dall’Ara, S. Piantoni, C. Donini, C. Agabiti Rosei, F. Bertacchini, D. Stassaldi, E. Agabiti Rosei, A. Tincani, M.L. Muiesan
Publicado em 2015-11-01

Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

Por P.L. Meroni, T. Avcin, V. Medeghini, A. Meini, A. Lojacono, M. Frassi, M. Nuzzo, Z. Shums, W.L. Binder, G.L. Norman, M. Motta, L. Andreoli, C. Nalli, A. Tincani
Publicado em 2011-09-01